Skip to main content
Caplight Logo









TripleMed

TripleMed

Private
GeleenHealthcare & Life Scienceshttps://www.triple-med.nl/

Last Round

VC Round

Mar 21, 2024

Total Funding Raised

$2.38M

Company Overview

TripleMed is a medical device company that develops innovative and cost-effective solutions for the treatment of aortic aneurysms.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

endovascular aneurysm repairEVARaortic aneurysm treatmentendoleak repairmedical devicepolymer implantvascular surgeryaneurysm sac fillingin-situ curingmedtechsiloxane polymerminimally invasive surgeryclinical trialvascular implant

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TripleMed Comparables

Compare TripleMed with similar companies based on industry and business-model similarity.

TripleMed comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Shape Memory Medical
79%
Endoron Medical
79%
Taurus Vascular
71%

TripleMed Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMar 21, 2024
Series ASep 1, 2017

TripleMed Investors

Notable investors and investment history

TripleMed investors
InvestorRounds
Brightlands Venture PartnersVC Round, Series A
LIOFVC Round, Series A

TripleMed Filings

Explore SEC and related filing metadata, where available.

TripleMed filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about TripleMed's valuation, stock price, and market status.

Is TripleMed a public or private company?

TripleMed is a private company.

What is the current stock price of TripleMed?

TripleMed is a private company with no public stock price. No recent secondary market data is available.

How much is TripleMed worth (valuation)?

Valuation information for TripleMed is not publicly available.

Can I buy TripleMed stock?

TripleMed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was TripleMed's last funding round?

TripleMed's most recent funding round was VC Round on March 21, 2024.

Who are the main investors in TripleMed?

Key investors in TripleMed include Brightlands Venture Partners, LIOF.

Will TripleMed IPO soon?

No public IPO plans have been announced for TripleMed.

How can I track TripleMed secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor TripleMed's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGeleen
Year Founded2011
Last FundingMar 21, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?